• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基葡萄糖激活肠道P-糖蛋白,抑制药物吸收。

Glucosamine activates intestinal P-glycoprotein inhibiting drug absorption.

作者信息

Wu Qinghua, Wang Qing, Luo Xiaohong, Jin Peng, Jin Ming, Hussain Sajid, Qi Yiming, Mo Junfeng, Yu Yinglan, Shao Hao, Luo Lei

机构信息

College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.

Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.

出版信息

Nat Commun. 2025 Jul 2;16(1):6100. doi: 10.1038/s41467-025-61437-2.

DOI:10.1038/s41467-025-61437-2
PMID:40603843
Abstract

P-glycoprotein (P-gp) is a crucial drug efflux transporter in the gastrointestinal tract, reducing drug uptake and expelling harmful xenobiotics to prevent pathological changes. Current P-gp enhancers primarily increase P-gp expression, requiring 1-3 days, thus missing the critical rescue window for acute poisoning. This study identifies glucosamine (GlcN) as a potent P-gp activator that swiftly enhances drug efflux, significantly reducing drug absorption without altering P-gp expression levels. GlcN directly binds to P-gp, boosting its transport efficiency. Only GlcN with a polymerization degree below 5 can activate P-gp, whereas higher polymerized chitooligosaccharides enhance drug absorption. Additionally, GlcN activation of P-gp has significant implications for cellular metabolism by expelling xenobiotics and metabolic by-products, maintaining cellular homeostasis. Our findings suggest GlcN's potential as an effective antidote for paraquat poisoning and offer a detoxification strategy. This research provides a foundational understanding for developing improved detoxification agents and metabolic modulators.

摘要

P-糖蛋白(P-gp)是胃肠道中一种关键的药物外排转运蛋白,可减少药物摄取并排出有害的外源性物质以预防病理变化。目前的P-gp增强剂主要是增加P-gp的表达,这需要1至3天,因此错过了急性中毒的关键抢救窗口。本研究确定氨基葡萄糖(GlcN)是一种有效的P-gp激活剂,可迅速增强药物外排,显著减少药物吸收,而不改变P-gp的表达水平。GlcN直接与P-gp结合,提高其转运效率。只有聚合度低于5的GlcN才能激活P-gp,而聚合度更高的壳寡糖则会增强药物吸收。此外,GlcN对P-gp的激活通过排出外源性物质和代谢副产物,维持细胞内稳态,对细胞代谢具有重要意义。我们的研究结果表明GlcN作为百草枯中毒有效解毒剂的潜力,并提供了一种解毒策略。这项研究为开发改进的解毒剂和代谢调节剂提供了基础认识。

相似文献

1
Glucosamine activates intestinal P-glycoprotein inhibiting drug absorption.氨基葡萄糖激活肠道P-糖蛋白,抑制药物吸收。
Nat Commun. 2025 Jul 2;16(1):6100. doi: 10.1038/s41467-025-61437-2.
2
Assessment of P-glycoprotein function using canine intestinal organoid-derived epithelial interfaces.使用犬肠道类器官衍生的上皮界面评估P-糖蛋白功能。
Xenobiotica. 2024 Jun;54(6):342-349. doi: 10.1080/00498254.2024.2358395. Epub 2024 Jun 24.
3
Decrease in In Vivo Efflux Transport via P-glycoprotein at the Rat Inner Blood-Retinal Barrier by Peripheral Administration of Lipopolysaccharide.外周给予脂多糖后大鼠血视网膜内屏障处P-糖蛋白介导的体内外排转运减少
Pharm Res. 2025 Jun 3. doi: 10.1007/s11095-025-03872-w.
4
Investigation of differentiation conditions for canine duodenum, upper jejunum, and ileum crypt-derived cells for drug transport and metabolism.犬十二指肠、空肠上段和回肠隐窝来源细胞用于药物转运和代谢的分化条件研究。
Drug Metab Dispos. 2025 Jun;53(6):100082. doi: 10.1016/j.dmd.2025.100082. Epub 2025 Apr 24.
5
Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.氨基葡萄糖逆转柔红霉素耐药人胃癌细胞中 P-糖蛋白介导的多药耐药性。
Nutr Cancer. 2020;72(3):522-527. doi: 10.1080/01635581.2019.1636102. Epub 2019 Jul 10.
6
P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.P-糖蛋白参与体外和大鼠中阿法替尼的肠道吸收和胆汁排泄。
Pharmacol Rep. 2018 Apr;70(2):243-250. doi: 10.1016/j.pharep.2017.10.005. Epub 2017 Nov 4.
7
Colchicine poisoning: the dark side of an ancient drug.秋水仙碱中毒:一种古老药物的黑暗面。
Clin Toxicol (Phila). 2010 Jun;48(5):407-14. doi: 10.3109/15563650.2010.495348.
8
Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.益生菌上调肠道上皮细胞 P-糖蛋白表达及葡聚糖硫酸钠诱导的结肠炎模型小鼠 P-糖蛋白表达。
Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1115-23. doi: 10.1152/ajpgi.00027.2011. Epub 2011 Feb 24.
9
The regulatory effects of mitragynine on P-glycoprotein transporter.帽柱木碱对P-糖蛋白转运体的调节作用。
J Pharm Pharmacol. 2025 Feb 3;77(2):321-334. doi: 10.1093/jpp/rgae131.
10
Reversible inhibition of efflux transporters by hydrogel microdevices.水凝胶微器件对外排转运蛋白的可逆抑制。
Eur J Pharm Biopharm. 2019 Dec;145:76-84. doi: 10.1016/j.ejpb.2019.10.007. Epub 2019 Oct 19.

本文引用的文献

1
Cryo-EM of human P-glycoprotein reveals an intermediate occluded conformation during active drug transport.人P-糖蛋白的冷冻电镜研究揭示了活性药物转运过程中的一种中间封闭构象。
Nat Commun. 2025 Apr 16;16(1):3619. doi: 10.1038/s41467-025-58561-4.
2
Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease.利用纳米马达进行口服线粒体移植治疗缺血性心脏病。
Nat Nanotechnol. 2024 Sep;19(9):1375-1385. doi: 10.1038/s41565-024-01681-7. Epub 2024 May 27.
3
Air-liquid intestinal cell culture allows rheological characterization of intestinal mucus.
气液肠道细胞培养可对肠道黏液进行流变学表征。
APL Bioeng. 2024 May 7;8(2):026112. doi: 10.1063/5.0187974. eCollection 2024 Jun.
4
Lack of CYP3A4 protein induction despite mRNA induction in primary hepatocytes exposed to rifabutin as a possible explanation for its low interaction risk in vivo.尽管在原代肝细胞中暴露于利福布汀时存在 CYP3A4 蛋白诱导,但缺乏 mRNA 诱导,这可能是其在体内低相互作用风险的原因。
Arch Toxicol. 2024 Aug;98(8):2541-2556. doi: 10.1007/s00204-024-03763-w. Epub 2024 May 7.
5
Osmotic Pressure and Its Biological Implications.渗透压力及其生物学意义。
Int J Mol Sci. 2024 Mar 14;25(6):3310. doi: 10.3390/ijms25063310.
6
Effects of Clarithromycin and Ketoconazole on FK506 Metabolism in Different CYP3A4 Genotype Recombinant Metabolic Enzyme Systems.克拉霉素和酮康唑对不同 CYP3A4 基因型重组代谢酶系统中 FK506 代谢的影响。
Curr Drug Metab. 2024;25(2):174-177. doi: 10.2174/0113892002286019240315052145.
7
Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis.胃肠道和大脑屏障:解锁微生物群-肠道-大脑轴上的沟通之门。
Nat Rev Gastroenterol Hepatol. 2024 Apr;21(4):222-247. doi: 10.1038/s41575-023-00890-0. Epub 2024 Feb 14.
8
Chitosan in Oral Drug Delivery Formulations: A Review.壳聚糖在口服给药制剂中的应用综述
Pharmaceutics. 2023 Sep 21;15(9):2361. doi: 10.3390/pharmaceutics15092361.
9
On the osmotic pressure of cells.论细胞的渗透压。
QRB Discov. 2022 Jul 11;3:e12. doi: 10.1017/qrd.2022.3. eCollection 2022.
10
Chitooligosaccharide reconstitutes intestinal mucus layer to improve oral absorption of water-soluble drugs.壳寡糖重建肠道黏液层以提高水溶性药物的口服吸收。
J Control Release. 2023 Aug;360:831-841. doi: 10.1016/j.jconrel.2023.07.035. Epub 2023 Jul 25.